automated peptide synthesizer aapptec focus xc (AAPPTec Inc)
90
Structured Review
AAPPTec Inc
automated peptide synthesizer aapptec focus xc
Automated Peptide Synthesizer Aapptec Focus Xc, supplied by AAPPTec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+peptide+synthesizer+aapptec+focus+xc/automated+peptide+synthesizer+aapptec+focus+xc/pmc11700610-38-20-19
Average 90 stars, based on 1 article reviews
Automated Peptide Synthesizer Aapptec Focus Xc, supplied by AAPPTec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+peptide+synthesizer+aapptec+focus+xc/automated+peptide+synthesizer+aapptec+focus+xc/pmc11700610-38-20-19
Average 90 stars, based on 1 article reviews
automated peptide synthesizer aapptec focus xc - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Construct:Article Title: Total synthesis of μ-conotoxin lt5d Article Snippet: .. Automated synthesis of precursor linear peptides was accomplished with an automated Article Title: Total synthesis of μ-conotoxin lt5d Article Snippet: .. Automated synthesis of precursor linear peptides was accomplished with an automated other:Article Title: Thrombopoietic agents enhance bone healing in mice, rats, and pigs Article Snippet: Thereafter, the following peptide sequence was added onto the peptide using the solid phase procedures listed above using the Article Title: The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors Article Snippet: Peptides were synthesized using an Synthesized:Article Title: Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development. Article Snippet: We report the discovery of sulanemadlin (ALRN6924), the first cell-permeating, stabilized α-helical peptide to enter clinical trials.. ALRN-6924 is a “stapled peptide” that mimics the Nterminal domain of the p53 tumor suppressor protein.. It binds with high affinity to both MDM2 and MDMX (also known as MDM4), the endogenous inhibitors of p53, to activate p53 signaling in cells having a non-mutant, or wild-type TP53 genotype (TP53-WT). Isolation:Article Title: Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development. Article Snippet: We report the discovery of sulanemadlin (ALRN6924), the first cell-permeating, stabilized α-helical peptide to enter clinical trials.. ALRN-6924 is a “stapled peptide” that mimics the Nterminal domain of the p53 tumor suppressor protein.. It binds with high affinity to both MDM2 and MDMX (also known as MDM4), the endogenous inhibitors of p53, to activate p53 signaling in cells having a non-mutant, or wild-type TP53 genotype (TP53-WT). High Performance Liquid Chromatography:Article Title: Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development. Article Snippet: We report the discovery of sulanemadlin (ALRN6924), the first cell-permeating, stabilized α-helical peptide to enter clinical trials.. ALRN-6924 is a “stapled peptide” that mimics the Nterminal domain of the p53 tumor suppressor protein.. It binds with high affinity to both MDM2 and MDMX (also known as MDM4), the endogenous inhibitors of p53, to activate p53 signaling in cells having a non-mutant, or wild-type TP53 genotype (TP53-WT). |